DOCU insider sales disclosed: 22,875 shares sold earlier, 1,682 planned
Rhea-AI Filing Summary
DOCUSIGN, INC. (DOCU) insider sale notice under Rule 144. The filer reports an intended sale of 1,682 restricted common shares, valued at $135,064.60, through Morgan Stanley Smith Barney on 09/15/2025 on NASDAQ. The shares were acquired as restricted stock from the issuer on 08/10/2024. The filing also discloses two recent sales by the same person: 983 shares sold on 09/11/2025 for $78,040.37 and a larger sale of 22,875 shares on 06/18/2025 for $1,710,777.77. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Compliance disclosure: The sale is reported under Rule 144 with broker details and seller certification
- Transaction details provided: Dates, amounts, broker, and aggregate values are explicitly stated
Negative
- Significant prior insider sale: 22,875 shares sold on 06/18/2025 for $1,710,777.77, which may be viewed as notable insider selling
Insights
TL;DR: Insider intends to sell a small remaining block after substantial prior disposals this year.
The filing shows an intended compliant sale of 1,682 restricted shares and documents two recent dispositions, notably a 22,875-share sale that generated about $1.71 million on 06/18/2025. From an insider-activity perspective, the pattern indicates material selling earlier in the year followed by a smaller planned sale. Such disclosures are routine under Rule 144 and facilitate market transparency, but the earlier large sale is the most materially relevant item for investors monitoring insider confidence.
TL;DR: Filing is procedural and compliant; prior large sale is noteworthy for governance monitoring.
The notice documents acquisition as restricted stock on 08/10/2024 and a scheduled broker-assisted sale on 09/15/2025. The inclusion of the seller's certification about material information and the use of a broker are consistent with expected controls. Governance teams will note the 06/18/2025 sale of 22,875 shares for $1,710,777.77 as the most significant disclosure here when assessing insider alignment with shareholders.